LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias.

Martina Berteotti, Francesco Profili, Besmir Nreu, Giancarlo Casolo, Alfredo Zuppiroli, Edoardo Mannucci, Rossella Marcucci, Paolo Francesconi

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD 2023;34(1):145-152

PMID: 37996368

Abstract

BACKGROUND AND AIMS

Lowering low-density lipoprotein cholesterol (LDL-C) is the cornerstone of cardiovascular disease prevention. Collection of epidemiological data is crucial for monitoring healthcare appropriateness. This analysis aimed to evaluate the proportion of high-risk patients who achieved guidelines recommended LDL-C goal, and explore the predictors of therapeutic failure, with a focus on the role of gender.

METHODS AND RESULTS

Health administrative and laboratory data from seven Local Health Districts in Tuscany were collected for residents aged ≥45 years with a history of major adverse cardiac or cerebrovascular event (MACCE) and/or type 2 diabetes mellitus (T2DM) from January 1, 2019, to January 1, 2021. The study aimed to assess the number of patients with optimal levels of LDL-C (<55 mg/dl for patients with MACCE and <70 mg/dl for patients with T2DM without MACCE). A cohort of 174 200 individuals (55% males) was analyzed and it was found that 11.6% of them achieved the target LDL-C levels. Female gender was identified as an independent predictor of LDL-C target underattainment in patients with MACCE with or without T2DM, after adjusting for age, cardiovascular risk factors, comorbidities, and district area (adjusted-IRR 0.58 ± 0.01; p < 0.001). This result was consistent in subjects without lipid-lowering therapies (adjusted-IRR 0.56 ± 0.01; p < 0.001).

CONCLUSION

In an unselected cohort of high-risk individuals, females have a significantly lower probability of reaching LDL-C recommended targets. These results emphasize the need for action to implement education for clinicians and patients and to establish clinical care pathways for high-risk patients, with a special focus on women.

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Address: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: [email protected].; Epidemiology Unit, Regional Health Agency (ARS) of Tuscany, Florence, Italy.; Diabetology Unit, Careggi university hospital, Florence, Italy.; Cardiology Unit, Versilia Hospital, Lido di Camaiore, Italy.; Former Department of Cardiology, Azienda Sanitaria di Firenze, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Diabetology Unit, Careggi university hospital, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.